Gene editing technologies like CRISPR are revolutionizing biotechnology, expanding from medical applications to diverse industries. Initially used for altering genes in human cells to cure previously ...

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...

French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for $9.5 billion, sending shares of the ...

An outbreak of Salmonella infections traced to cucumbers from Florida is growing. As of May 30, 45 people across 18 states had been infected. Sixteen ...

PharmAla says its LaNeo MDMA drug products are exclusively available through a qualified practitioner’s prescription and ...

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.

The expo provided a glimpse into the future of biotechnology, highlighting how technology is set to revolutionize healthcare and medical sectors worldwide. Meanwhile, the presence of esteemed media ...

Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine. The Cambridge, Massachusetts-based biotech is also laying off staffers and CEO ...

-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology -- -- On-track to file IND ...